Date : 2026/02/10
Company : MicroBase Technology Corp.
Subject: MicroBase(3184) is the First Company in Taiwan to Obtain EU MDR Certification for Hands-Free Mesh Nebulizer.
Spokesperson: Rick Liu
Statement:
1. Date of actual occurrence: 2026/02/10
2. Company name: MicroBase Technology Corp..
3. Relationship with the company (please enter the company or subsidiary): The company
4. Mutual shareholding ratio: Not applicable
5. Reasons for the occurrence:Our company respiratory care brand PocketAir, has passed the review of the European Union’s highest medical device regulatory standards and obtained EU MDR dual-product certification. Among these, the"GOCare Portable Nebulizer" is the first hands-free mesh nebulizer product in Taiwan to obtain EU MDR certification for the home care market, while the "LoyalCare Nebulizer System" has officially entered the respiratory disease medical market. The acquisition of EU MDR certification not only accelerates the expansion of the respiratory care market but also strengthens the Company's role as a key technology provider in the fields of personalized medicine and precision drug delivery.
6. Response measures:Announce latest information.
7. Other items that should be stated: None
| Date | Announcements |
| 2025/04/01 | Announcement of the Board of Directors' resolution to convene the 2025 Annual General Meeting |
| 2025/04/01 | Announcement of the Board of Directors' approval of the 2024 consolidated financial statements |
| 2025/04/01 | Announcement of the Board of Directors' resolution not to distribute dividends |
| 2025/05/13 | Announcement of the Board of Directors' resolution on capital reduction to offset losses |
| 2025/05/13 | Announcement of the Board of Directors' resolution to convene the 2025 Annual General Meeting (Added Agenda) |
| 2025/06/26 | Announcement of important resolutions from the 2024 Annual General Meeting |
| 2025/06/26 | Announcement to creditors regarding capital reduction |
| 2025/07/31 | Announcement of the Board of Directors' approval of the consolidated financial statements for the first half of 2025 |
| 2025/09/23 | Announcement of the Chairman's determination of the capital reduction record date, share replacement plan, and record date for share replacement |
| 2025/10/23 | Announcement of the completion of registration for capital reduction |
|
Date |
Announcements |
|
2024/01/25 |
Change of representative of legal person director. |
| 2024/03/20 |
The board of directors approved the consolidated financial statements for the FY24. |
| 2024/03/20 |
The board of directors resolved to hold the 2024 shareholders meeting related matters. |
| 2024/03/20 |
The board of directors resolved not to distribute dividends. |
| 2024/09/12 |
Obtaining Taiwan Medical Device License for LoyalCare Nebulizer System. |
Date : 2024/09/12
Company : MicroBase Technology Corp.
Subject: MicroBase Obtaining the Taiwan Medical Device License for LoyalCare Nebulizer System
Spokesperson: Rick Liu
Statement:
1. Date of actual occurrence: 2024/09/12
2. Company name: MicroBase Technology Corp..
3. Relationship with the company (please enter the company or subsidiary): The company
4. Mutual shareholding ratio: Not applicable
5. Reasons for the occurrence: Our company has obtained the Taiwan Food and Drug Administration (TFDA) approval for the LoyalCare Nebulizer System. This nebulizer system is designed for use in intensive care units and long-term care facilities, providing a safe and efficient method of delivering aerosolized medication to patients requiring mechanical ventilation or other positive pressure ventilation support.
6. Response measures: None
7. Other items that should be stated: None
|
Date |
Announcements |
|
2023/08/11 |
MicroBase applied“Intelligent Drug Delivery System” was approved by Act for the Development of Biotech and Pharmaceutical Industry. |
|
2023/08/10 |
The board of directors approved the consolidated financial statements for the FY23 half year. |
|
2023/06/19 |
By-election of a supervisor at the 2023 shareholders annual meeting. |
|
2023/06/19 |
Important resolutions of the 2023 Shareholders annual meeting. |
|
2023/05/18 |
2023 first issuance of employee stock option certificates and share subscription measures. |
|
2023/05/18 |
The board of directors ratifies and revises the first employee stock option certificate issuance and share subscription method in 2023. |
|
2023/05/15 |
Change of representative of legal person director. |
|
2023/03/15 |
The board of directors resolved not to distribute dividends. |
|
2023/03/15 |
The board of directors resolved to issue 2023 employee stock option certificates. |
|
2023/03/15 |
The board of directors resolved to hold the 2023 shareholders meeting related matters. |
Date : 2023/08/11
Company : MicroBase Technology Corp.
Subject: MicroBase "Intelligent Drug Delivery System" approval of the Act for the Development of Biotech and Pharmaceutical Industry.
Spokesperson: Rick Liu
Statement:
1. Date of actual occurrence: 2023/08/11
2. Company name: MicroBase Technology Corp..
3. Relationship with the company (please enter the company or subsidiary): The company
4. Mutual shareholding ratio: Not applicable
5. Reasons for the occurrence: The company applied to Industrial Development Bureau, Ministry of Economic Affairs for approval as a "biotechnology and pharmaceutical company" with the "Intelligent Drug Delivery System". According to the "Act for the Development of Biotech and Pharmaceutical Industry", the company complies with the "Biotechnology and Pharmaceutical Industry Development Regulations" Article 4, Item 1, Paragraph 2, item 1 and Article 2, Item 1, Paragraph 1 of the "Measures for the Examination and Approval of Biotechnology and Pharmaceutical Companies", and received the approval letter today.
6. Response measures: Announce latest information.
7. Other items that should be stated: None